
GWAS Reveals Genetic Variants Impacting Tamoxifen Metabolism in American Males
Reading Time: 2 minutes Introduction Tamoxifen, a cornerstone in the treatment of hormone receptor-positive breast cancer, has been extensively studied for its efficacy and metabolism. While predominantly used in females, its application in male breast cancer patients is equally significant. Recent advances in genome-wide association studies (GWAS) have shed light on the genetic factors that influence tamoxifen metabolism, particularly in American males. This article delves into the findings of a pivotal study that explores these genetic determinants, offering new insights into personalized medicine and treatment optimization. Study Overview and Methodology The study in question conducted a comprehensive GWAS to identify genetic variants associated with...